SCM
COGT icon

Suvretta Capital Management’s Cogent Biosciences COGT Stock Holding History

Suvretta Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-316,000
Closed -$2.12M – 101
2024
Q1 		$2.12M Sell
316,000
-3,394,539
-91% -$21M 0.09% 74
2023
Q4 		$21.8M Buy
3,710,539
+657,239
+22% +$5.04M 1% 33
2023
Q3 		$29.8M Buy
3,053,300
+833,607
+38% +$9.89M 1.61% 20
2023
Q2 		$26.3M Buy
2,219,693
+400,000
+22% +$4.59M 1.41% 25
2023
Q1 		$19.6M Buy
1,819,693
+8,297
+0.5% +$106K 0.95% 41
2022
Q4 		$20.9M Sell
1,811,396
-51,204
-3% -$635K 0.88% 39
2022
Q3 		$27.8M Buy
1,862,600
+1,262,600
+210% +$17.3M 1.17% 35
2022
Q2 		$5.41M Buy
+600,000
New +$4.1M 0.21% 63

Other funds holding COGT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return